Introduction
The number of renal transplantations with living donor kidneys is progressively increasing world-wide, thus increasing the necessity of detailed knowledge about the short-term and long-term risks involved in this procedure [1] . Increased blood pressure and creatinine levels, hypertension and proteinuria are associated with unilateral nephrectomy in human subjects (reviewed in [2] ). However, the factors contributing to the adaptations of the remaining kidney have not been systematically evaluated.
Animal models of reduced renal mass undergo a series of adaptive mechanisms to maintain sodium homeostasis. As the population of surviving nephrons is reduced, the remaining tissue undergoes compensatory hypertrophy with marked alterations in tubular reabsorptive capacities of sodium and water [3] [4] [5] . Compensatory changes in the tubular handling of sodium include an increased excretion of sodium per nephron [6, 7] . In this way, sodium balance can be maintained despite a diminishing glomerular filtration rate, when salt intake is unaltered under conditions of reduced renal mass. In rats submitted to uninephrectomy, an increased renal dopamine synthesis was observed in the rat remnant kidney at 2 weeks after surgery. This was accompanied by a dopamine-sensitive enhanced natriuresis with no changes in blood pressure values, suggesting that after uninephrectomy renal dopamine may play an important role in keeping uninephrectomized (Unx) rats within sodium balance [8, 9] . The role of the renal dopaminergic system in sodium handling in more early phases after renal mass ablation still remains to be established.
Dopamine of renal origin exerts natriuretic and diuretic effects by activating D1-like receptors located at various regions in the nephron [10, 11] . At the level of the proximal tubule, the overall increase in sodium excretion produced by dopamine and D1 receptor agonists results from inhibition of the main sodium transport mechanisms at the basolateral and apical membranes, respectively, Na + -K + -ATPase and the Na + /H + exchanger [12] [13] [14] [15] [16] . On the other hand, sodium has been found to constitute an important stimulus for the production of dopamine by renal proximal tubule cells [17] [18] [19] , resulting in increases in the urinary excretion of dopamine and dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) [9, [20] [21] [22] [23] .
The proximal tubules, but not distal segments of the nephron, are endowed with high aromatic L-amino acid decarboxylase (AADC) activity, and epithelial cells of proximal tubules have been demonstrated to synthesize dopamine from circulating or filtered L-3,4-dihydroxyphenylalanine (L-DOPA) [24] [25] [26] . Studies on the inward transport of L-DOPA by tubular epithelial cells conducted in rat renal cortical slices [27] and cultured renal cell lines [13, 28] demonstrated that uptake of L-DOPA is an active process, mediated through amino acid transporters. The candidate transport systems for L-DOPA may include the Na + -dependent systems B 0 , B 0,+ and y + L, and the Na + -independent systems L-amino acid transporters (LAT1 and LAT2) and b 0,+ [13, 19, [28] [29] [30] [31] [32] . Our group has suggested that the L-DOPA transport in immortalized renal proximal tubular epithelial cells of Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR) is mediated by LAT2 [33] . Furthermore, we have recently reported the presence of an adaptive regulation of renal amino acid reabsorptive mechanisms in response to acute dietary Na + changes [34] . Relative to other amino acid transporters, the expression levels of the Na + -dependent amino acid exchanger ASCT2 and the heterodimeric transporter LAT1-4F2hc are elevated in a variety of cancer types, suggesting a potential role in cellular growth. This upregulation of ASCT2 and LAT1 supports the high levels of protein synthesis necessary for continuous growth and proliferation, via delivery of glutamine and essential amino acids such as leucine, respectively [35] .
The hypothesis that we have explored in the present study concerns the occurrence of adaptations in the remnant kidney, especially in renal amino acid transporters and sodium transporters and their putative role in sodium handling in the early stages after uninephrectomy.
Materials and methods

Animal interventions
All animal interventions were performed in accordance with the European Directive number 86/609, and the rules of the 'Guide for the Care and Use of Laboratory Animals', 7th edition, 1996, Institute for Laboratory Animal Research (ILAR), Washington, DC.
Wistar rats aged 8 weeks old and weighing 214-253 g were used in the experiments. The animals were kept under controlled environmental conditions (12 h light/dark cycle and room temperature 22 ± 2 • C), and fluid intake and food consumption were monitored daily throughout the study. All animals were fed ad libitum throughout the study with ordinary rat chow.
The rats were anaesthetized with pentobarbital sodium (60 mg/kg, ip), and the surgical ablation of the right kidney was performed according to that previously described [9] -Unx rats (n = 10). The control animals were rats submitted to sham surgery under similar conditions; however, their kidneys remained intact-sham-operated (Sham) rats (n = 10). After total recovery from surgery (4-6 h), the rats returned to the animal facility, where they had free access to food and water. The survival rate was 100%.
Twenty-four hours (24-h Unx rats; n = 5) and 1 week (1-week Unx rats; n = 5) after surgery, the rats were placed in metabolic cages. Twentyfour-hour urine was collected for the quantification of sodium, creatinine, urea and catecholamines. The vials collecting urine for the quantification of catecholamines contained 0.5 ml hydrochloric acid (6 M), to avoid the spontaneous oxidation of the amines and its derivatives.
Afterwards, the rats were anaesthetized with pentobarbital sodium (60 mg/kg, ip) and blood was collected from the heart in tubes containing K 3 EDTA for a later determination of plasma catecholamines and biochemical parameters. The animals were perfused through injection of 50 ml of ice-cold PBS in the left ventriculum. The kidneys were then rapidly removed, decapsulated and weighed. Thereafter, cortices were dissected out, snap-frozen in liquid nitrogen and stored at −80 • C until processing for protein and RNA extraction.
Assay of catecholamines
The assay of catecholamines and its derivatives in urine and plasma samples (L-DOPA, dopamine, DOPAC, norepinephrine and epinephrine) was performed by HPLC with electrochemical detection, as previously described [19, 28] . The lower limit of detection of L-DOPA, dopamine, DOPAC, norepinephrine and epinephrine ranged from 350 to 1000 fmol. Renal delivery of L-DOPA was calculated according to the formula (plasma L-DOPA × creatinine clearance).
Plasma and urine ionogram and biochemistry
The quantification of sodium, urea and creatinine in plasma and urine samples was performed by Cobas Mira Plus analyser (Horiba ABX, France) as previously described [8] .
RNA extraction
Kidney cortices were homogenized (Diax, Heidolph-Sigma-Aldrich, USA) in Trizol reagent (75 mg/ml; Invitrogen, USA), and total RNA was extracted according to the manufacturer's instructions. The RNA obtained was dissolved in diethylpyrocarbonate (DEPC)-treated water and quantified by spectrophotometry at 260 nm.
Reverse transcription
The total RNA extracted from individual rat kidney cortices was treated with DNase (Ambion, USA), to eliminate potential genomic DNA contamination. cDNA was synthesized from 1 µg of total RNA in a total volume of 20 µl. Reverse transcription was performed with the SuperScript First Strand System for RT-PCR (Invitrogen, USA), using 250 ng/µl random hexamers as primers at 50 • C, according to the manufacturer's instructions. For real-time quantitative PCR, 2 µl out of the 20 µl reverse transcription reaction mixture was used.
Standard preparation
Standards for amino acid transporters and GAPDH were obtained by conventional PCR amplification, using TaqPCRx DNA polymerase (Life Technologies, USA) and the following rat specific primers: rLAT1 forward primer 5 -CTC CT GCC CAT TGT CAC-3 and reverse primer 5 -GGT AGT TCC CAA AAT CCA CAG-3 (position 855 and 950 bp in the rat LAT1 sequence AB015432); rLAT2 forward primer 5 -TCG CTG TGA CTT TTG GAG AGA-3 and reverse primer 5 -CGG GAG GAG GTG AAGAGG-3 (position 908 and 1002 bp in the rat LAT2 sequence AB024400); r4F2hc forward primer 5 -GTC ACA GCC CGT TTTCAC T-3 and reverse primer 5 -CCT GCC TGC GAC ACA CTCC-3 (position 897 and 980 bp in the rat 4F2hc sequence NM019283); rASCT2 forward primer 5 -CGT CCT CAC TCTTGC CAT CAT-3 and reverse primer 5 -CCA AAA GCA TCA CCC TCC AC-3 (position 1298 and 1427 bp in the rat ASCT2 sequence NM175758); rNHE3 forward primer 5 -GCC AAA ATC GTC TTC CAT CT-3 and reverse primer 5 -GTA CCC AGC ATC CAA CAC AAT-3 (position 281F and 466R bp in the rat NHE3 sequence NM012654); rNa + -K + -ATPase α1 forward primer 5 -GCA GGG AAT GAA GAA CAA GA-3 and reverse primer 5 -GAA GAT GAG AAG GGA GTA GGG-3 (position 3075 and 3214 bp in the rat Na + -K + -ATPase α1 sequence NM012504); and rGAPDH forward primer 5 -GGC ATC GTG GAA GGG CTC ATG AC-3 and reverse primer 5 -ATG CCA GTG AGC TTC CCG TTC AGC-3 (position 716 and 800 bp in the rat GAPDH sequence M17701).
PCR products were gel-purified with Qiaex II (Qiagen, Germany) and quantified by spectrophotometry at 260 nm. The concentration was determined, and the DNA was diluted accordingly in serial steps. PCR fragments were cloned and sequenced.
Quantitative real-time PCR (RT-PCR)
RT-PCR was carried out using a LightCycler (Roche, Switzerland), as previously described [34] . Briefly, each RT-PCR reaction mixture (20 µl) included reverse transcription products corresponding to 25 ng of total RNA or standard DNA, 1× SYBR Green I master mix (LightCycler FastStart DNA Master PLUS SYBR Green I, Roche, Switzerland) and 0.5 µM of each forward and reverse primers (described previously). Cycling conditions were as follows: denaturation (95 • C Amplification specificity was checked using melting curves following the manufacturer's instructions. In addition, PCR products were separated by electrophoresis in a 2% TBE agarose gel to confirm the correct band sizes. Results were analysed with LightCycler Software version 3.5 (Roche, Switzerland) using the second derivate maximum method. Quantification was performed using standard curves. Data were normalized to the expression of the constitutively expressed gene GAPDH.
Immunoblotting
Renal cortical membranes from Wistar rats Unx and sham-operated for 24 h and 1 week were washed with PBS and then lysed in a RIPA buffer containing 150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 5 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 100 µg/ml PMSF, 2 µg/ml leupeptin and 2 µg/ml aprotinin. The protein concentration was determined using a protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA), with bovine serum albumin as standard. Cell lysates were boiled in a sample buffer (35 mM Tris-HCl, pH 6.8, 4% SDS, 9.3% dithiothreitol, 0.01% bromophenol blue, 30% glycerol) at 95 • C for 5 min. Samples containing 50-75 µg of protein were separated by SDS-PAGE with a 10% polyacrylamide gel and then electroblotted onto nitrocellulose membranes (Bio-Rad). Blots were blocked for 1 h with 5% non-fat dry milk in PBS (10 mmol/l phosphate-buffered saline) at room temperature with constant shaking. The blots were then incubated with the antibodies goat polyclonal anti-LAT2 (1:800; Santa Cruz Biotechnology, USA); rabbit anti-LAT1 (1:500; Serotec, AbD Serotec, Germany); rabbit polyclonal anti-ASCT2 (1:500; Chemicon International, USA); rabbit polyclonal anti-NHE3 1:500 (as previously described [16] ); mouse monoclonal anti-Na + -K + -ATPase α1 (1:5000; Santa Cruz Biotechnology, USA); or mouse monoclonal anti-β-actin (1:20 000; Santa Cruz Biotechnology, USA), in 5% non-fat dry milk in PBS-T overnight at 4 • C. The immunoblots were subsequently washed and incubated with fluorescently labelled goat anti-rabbit (1:10 000; IRDye Tm 800, Rockland, USA); fluorescently labelled donkey anti-goat (1:10 000; IRDye Tm 800, Rockland, USA); or the fluorescently labelled goat anti-mouse secondary antibody (1:10 000; AlexaFluor 680, Molecular Probes, USA) for 60 min at room temperature and protected from light. The membrane was washed and imaged by scanning at both 700 nm and 800 nm, with an Odyssey Infrared Imaging System (LI-COR Biosciences, USA).
Statistical methods
Data are presented as means ± SEM. Statistical analysis was performed by one-way analysis of variance (ANOVA) followed by Student's t-test or the Newman-Keuls test for multiple comparisons. A P-value < 0.05 was assumed to denote a significant difference. Table 1 summarizes the physiological parameters of the 8-week-old Unx and sham-operated Wistar rats for 24 h and 1 week. Uninephrectomy had no effect on body growth, as Unx rats attained the same weight as did Sham rats. Twenty-four-hour uninephrectomy showed no differences in the remnant kidney weight between Unx and Sham rats. Kidney weight 1 week after surgery, however, was significantly altered; the Unx rats presented a hypertrophied remnant kidney weighing 20.1 ± 6.3% more than the corresponding kidney in Sham rats. Urine volume showed no differences in 24-h Sham and Unx rats, but increased significantly in 1-week Unx versus Sham rats. Plasma urea was greater in Unx rats 24 h and 1 week after surgery, while plasma creatinine was similar between Unx and Sham rats. Creatinine clearance decreased in 24-h and 1-week Unx rats, although this difference did not achieve statistical significance. Uninephrectomy had no influence in the fractional excretion of sodium of 24-h Unx rats, but led to an ∼2-fold increase in 1-week Unx rats.
Results
Renal function of Unx rats
The urinary excretion of L-DOPA, dopamine, DOPAC, noradrenaline and adrenaline were decreased in Unx rats at 24 h, but showed no differences 1 week after uninephrectomy. In addition, the levels of plasma L-DOPA were similar between Unx and Sham rats throughout the study, while the renal delivery of L-DOPA was significantly decreased in both 24-h and 1-week Unx rats. Urinary dopamine plus DOPAC divided by L-DOPA delivery showed a significant increase 1 week after surgery (Figure 1) .
Effect of uninephrectomy on mRNA transcript abundance
Transcript abundance of amino acid transporters and sodium transporters was measured by quantitative RT-PCR. As shown in Figure 2A , renal LAT1 transcript levels in Unx rats were significantly higher than in Sham rats at both 24 h and 1 week after uninephrectomy (36 ± 11% and 43 ± 12% increase, respectively). On the other hand, uninephrectomy led to a significant decrease in both LAT2 and 4F2hc mRNA levels of 24-h Unx rats (36 ± 4% lower in both cases), while 1 week after surgery this difference was no longer observed ( Figure 2B and C) . No significant changes were found in either group in the mRNA expression of the Na + -dependent amino acid transporter ASCT2 Values are mean ± SEM; n = 5 experiments/group. C creatinine = creatinine clearance; FE Na + = fractional excretion of Na + . a Significantly different from corresponding values in sham-operated rats (P < 0.05).
( Figure 2D ). Concerning the sodium transporters, NHE3 transcript quantification showed a significant decrease in Unx rats for 24 h (23 ± 5% lower) and for 1 week (19 ± 5% lower), while the Na + -K + -ATPase expression remained unchanged throughout the study ( Figure 2E and F) .
Effect of uninephrectomy on protein abundance
The protein expression of amino acid transporters and sodium transporters was assessed by means of immunoblotting. The protein expression levels of LAT1 were significantly higher in Unx rats than in Sham rats at 24 h (67 ± 19%) and 1 week (60 ± 20%) after nephrectomy ( Figure 3A) . When compared to Sham rats, 4F2hc protein abundance was 37 ± 5% lower in Unx rats at 24 h, with no changes 1 week after surgery ( Figure 3C ). There were no significant differences in the expressions of the Na + -independent transporter LAT2 and the Na + -dependent transporter ASCT2 (Figure 3B and D) . Since 4F2hc is required to bring LAT1 and LAT2 to the cell membrane [36, 37] , which is essential for the latter to be operational [34, 38] , the LAT1/4F2hc and LAT2/4F2hc kidney ratios are assumed to reveal the functionality of the transporters. These ratios were obtained by the simultaneous quantification of the LAT2 and 4F2hc protein expression from the same blots. Twenty-four hours after uninephrectomy, the LAT1/4F2hc ratio was significantly higher in Unx rats (1.7 ± 0.18) than in Sham rats (1.0 ± 0.12). This increased expression of LAT1 over 4F2hc does not necessarily mean that a significant number of LAT1 units are not functional, but may alternatively suggest an enhanced turnover of LAT1 transport units. A higher LAT1/4F2hc ratio was still present 1 week after uninephrectomy (1.3 ± 0.12 and 1.0 ± 0.11 in Unx and Sham rats, respectively), although in this case it did not represent a statistically significant difference. No significant differences occurred at either 24 h or 1 week post-nephrectomy on LAT2/4F2hc ratios (data not shown). The protein expression of the apical sodium transporter NHE3 was ∼20% lower both at 24-h and 1-week Unx rats, although this did not attain a significant difference ( Figure 3E ). In contrast, the expression of the basolateral transporter Na + -K + -ATPase showed a significant increase of 64 ± 18% at 24 h, with no differences 1 week after surgery ( Figure 3F ).
Discussion
This study provides evidence that the renal expression of the amino acid transporters LAT1, LAT2 and 4F2hc and the sodium transporters Na + -K + -ATPase and NHE3 is differently regulated following unilateral nephrectomy, suggesting a potential role in the functional adaptations of the remnant kidney.
Furthermore, uninephrectomy was associated with the known consequences of partial renal ablation, namely, compensatory renal growth, significant azotaemia, significant increase in fractional excretion of sodium and dopamine synthesis and changes in solute transport [6, 24, 39] , these effects being particularly evident in 1-week Unx rats rather than 24 h after surgery. In fact, Unx rats for 24 h presented a decrease in the renal delivery of L-DOPA and decreased urinary excretion of dopamine and its deaminated metabolite DOPAC, which suggest a reduced renal synthesis of dopamine. At this stage, Unx rats presented no renal hypertrophy and no changes in FE Na + , but showed an increase in the expression of the Na + -K + -ATPase protein. The discrepancy between mRNA levels and protein expression observed in Na + -K + -ATPase might be related to post-transcriptional regulation, such as the control of splicing efficiency, precursor RNA stability, polyadenilation or RNA transport [40] . Several studies have indicated an enhancement of sodium transport early after uninephrectomy, evidenced by an increase in Na + -K + -ATPase activity, which disappears with progressive renal growth [41] [42] [43] . Two weeks after uninephrectomy, Na + -K + -ATPase activity in renal proximal tubules has been found to be similar to that in corresponding controls [9, 44] . These findings are in agreement with the results reported here at 1 week after surgery, since at this stage, the early increase in the Na + -K + -ATPase protein expression and reduced dopamine synthesis are no longer present in the hypertrophied kidney of Unx rats. The 1.8-fold increase in [FE Na + in 1-week Unx rats contrasts with the results on the Na + -K + -ATPase protein expression, unless one assumes that the slightly decreased protein abundance of the sodium transporter NHE3 may contribute to the enhanced Na + excretion in 1-week Unx rats. This possibility, however, has to be considered with caution since increases in FE Na + in Unx rats are usually associated with post-proximal sodium excretion mechanisms [45, 46] . Renal LAT1 transcript and protein quantification revealed a sustained overexpression throughout the study. As discussed previously, this amino acid transporter is involved in continuous cell growth and proliferation. Recent studies have demonstrated that LAT1 is a major L-type amino acid transporter in a variety of cancer cells including hepatic, oral, breast, bladder and colon [47] . LAT1 preferentially mediates the sodium-independent transport of large neutral amino acids such as leucine, isoleucine, valine, phenylalanine, tyrosine, tryptophan, methionine and histidine and is a major route for providing tumour cells with branched and aromatic amino acids [48] . Originally identified in activated lymphocytes and in rat hepatomas [49] , the primary tissues displaying high expression of LAT1 thus either contain many proliferating cells, such as bone marrow, or contain endothelial and/or epithelial barriers that display vectorial, secretory amino acid transport from the extracellular space into other compartments, such as placenta, blood-brain barrier, ovary, testes and mammary glands [50, 51] . Furthermore, LAT1 is also expressed in regenerating liver after partial hepatectomy [50] . At the kidney level, LAT1 has a very limited tissue distribution and, to our knowledge, there is no report on the exact localization of LAT1 in the nephron [34] . Nevertheless, Soares-da-Silva and Serrao described the transport of leucine by LAT1 in pig LLC-PK1 renal cells [31] . Although LAT1 has been shown to be present in brain capillary endothelial cells, its presence in the renal vasculature has not been defined. It is well established that shortly after unilateral nephrectomy, enhanced cell proliferation is demonstrable in the remaining contralateral kidney [52] . Compensatory renal growth is characterized by cell-cycle arrest in the G1 phase. As compensation for the nephron loss and in order to augment work capacity and maintain normal renal function, the remaining nephrons increase their RNA and protein synthesis with minimal alterations in DNA replication. Additionally, there is an inhibition of protein degradation and turnover contributing to cell enlargement and increased total cellular protein content [53] [54] [55] . These changes increase residual kidney size, but not the number of existing renal cells. While the bulk of compensatory organ growth can be attributed primarily to the hypertrophy of the proximal tubular epithelial cells, other kidney cells may actively participate in the process [52] . Morphological and stereological analysis performed by Pfaller et al. show that the distal convoluted tubules and the cortical collecting duct undergo 'length' hypertrophy (increase of tubular length without thickening of the tubular wall and without an increase in number of cells), participating in compensatory kidney enlargement 10 and 21 days after unilateral nephrectomy [56] . Four and 24 days after uninephrectomy, SeyerHansen et al. also detected an increase in total glomerular volume and glomerular filtration surface, although this glomerular hypertrophy was less pronounced than tubular growth [57] . Other studies detected an increase in interstitial blood vessel volume and an overall remodelling and proliferation in renal cortical peritubular capillaries after experimental nephron reduction [58, 59] . Therefore, LAT1 should be expected to be increased in the different cell types and tissues along the nephron (epithelial, interstitial and vascular cells) in order to provide cells with essential amino acids for high levels of protein synthesis associated with cell activation or hormonal stimulation and also to sustain kidney growth associated with renal mass reduction [60] . 4F2hc is a glycoprotein heavy chain that associates with the catalytic light chain LAT1 forming a heterodimeric transporter and is thought to be involved in the trafficking of the complex to the plasma membrane. Even so, the increased LAT1/4F2hc ratio in 1-week Unx rats does not necessarily compromise the transport activity or surface expression of LAT1, but may alternatively suggest an enhanced turnover of LAT1 transport units. Studies on the function and structure of heterodimeric amino acid transporters using truncated mutants of 4F2hc demonstrated that LAT1 retains its antiport mechanism when the extracellular domain of 4F2hc, responsible for the recognition of light chains, is completely removed and that the disulfide bridge connecting the dimers is not necessary for the surface expression of LAT1 [61, 62] . Furthermore, Wagner et al. reported that rBAT, the other known heavy chain, is able to translocate LAT1, LAT2 and y + LAT1 to the plasma membrane when coexpressed with these light chains in Xenopus laevis oocytes [63] .
In contrast to LAT1, the Na + -dependent ASCT2 expression, another transporter associated with cellular growth, remained unchanged throughout the study, suggesting that the mechanisms involved in compensatory hypertrophy may differ from that described for tumoural cells.
LAT2 is a major Na + -independent amino acid transporter with marked expression in transporting epithelia, namely in the kidney and intestine, and its functionality is dependent on the abundance of 4F2hc. The heterodimerization of LAT2 with 4F2hc is a prerequisite for the transporter to reach the cell surface. Moreover, the glycoprotein may regulate the functional surface expression of the transporter [36] [37] [38] 64] . Therefore, parallel decreases in renal 4F2hc protein and transcript and LAT2 transcript in Unx rats for 24 h may actually translate into decreases in LAT2 functionality. These results correlate well with the decreased synthesis of dopamine, since LAT2 is suggested to mediate the inward transport of L-DOPA [33] . This correlation is further evident when dividing urinary dopamine plus DOPAC by delivery of L-DOPA, which shows no difference between Unx rats and Sham rats 24 h after surgery. In fact, Unx rats for 24 h presented a reduced L-DOPA delivery and a general decreased urinary excretion of catecholamines, reflecting the renal mass reduction and the consequent diminished glomerular filtration rate. Thus, the basic mechanisms for the regulation of the dopaminergic system, which appear to depend on the availability of L-DOPA, its fast decarboxylation into dopamine and in precise and accurate cell outward amine transfer mechanisms, seem to be compromised [65] . The fact that these effects were no longer present 1 week after surgery, suggest that they were one of the first functional adaptations following the left kidney ablation. At this stage and despite the sustained decrease in the delivery of L-DOPA, urinary dopamine showed no difference between Sham and Unx rats. The ratio urinary dopamine plus DOPAC/L-DOPA delivery showed a significant increase in Unx rats, which may indicate an increased dopamine synthesis 1 week following uninephrectomy. Furthermore, 1 week after surgery, Unx rats showed no differences in the LAT2/4F2hc expression and the urinary levels of catecholamines parallel to the ones in Sham-operated animals, suggesting a compensatory mechanism of the remaining kidney to overcome the renal mass reduction and increase the synthesis of dopamine. Recently, in an uninephrectomy experimental model in rats, the role of the renal dopaminergic system in the control of sodium homeostasis showed time-dependent variations, suggesting that natriuretic dopamine assumes a particular importance 2 weeks after uninephrectomy, but not in later phases (10 and 26 weeks) [66] . In fact, there is a general consensus regarding the renal adaptations beyond 2 weeks after left kidney ablation, characterized by an increased renal dopaminergic activity, enhanced diuresis and natriuresis and renal hypertrophy [8, 9, 67, 68] . Unlike these reports, 24 h after surgery, we observed a diminished dopamine urinary excretion with no differences in natriuresis or renal growth. However, 1 week after surgery, Unx rats showed increased dopamine synthesis and fractional excretion of sodium as well as compensatory kidney growth, suggesting a tendency to match the alterations observed 2 weeks after nephrectomy.
In conclusion, this study allowed us to characterize the renal adaptations in the early stages after uninephrectomy, which showed a combined interaction of multiple mechanisms regulating sodium homeostasis including the renal dopaminergic system, and the abundance of amino acid transporters and sodium transporters.
